These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 12822234)
21. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study. Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326 [TBL] [Abstract][Full Text] [Related]
22. [Type 2 diabetics are high risk patients. Concerning LDL-cholesterol to approach effectively to two sources]. MMW Fortschr Med; 2005 Nov; 147(44):52-3. PubMed ID: 16302495 [No Abstract] [Full Text] [Related]
24. Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment. Lind S; Olsson AG; Eriksson M; Rudling M; Eggertsen G; Angelin B J Intern Med; 2004 Nov; 256(5):406-12. PubMed ID: 15485476 [TBL] [Abstract][Full Text] [Related]
25. Does ENHANCE diminish confidence in lowering LDL or in ezetimibe? Brown BG; Taylor AJ N Engl J Med; 2008 Apr; 358(14):1504-7. PubMed ID: 18376002 [No Abstract] [Full Text] [Related]
26. [Recommended LDL value far lower. How does one achieve this goal?]. Einecke D MMW Fortschr Med; 2004 Mar; 146(13):6. PubMed ID: 15219116 [No Abstract] [Full Text] [Related]
27. [Lowering LDL cholesterol frequently does not adhere to guidelines. Also regard intestinal cholesterol source]. MMW Fortschr Med; 2005 Jun; 147(23):48-9. PubMed ID: 15981908 [No Abstract] [Full Text] [Related]
29. Is carotid intima-media thickness a reliable clinical predictor? Spence JD Mayo Clin Proc; 2008 Nov; 83(11):1299-300; author reply 1300-1. PubMed ID: 18990332 [No Abstract] [Full Text] [Related]
30. [Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl]. MMW Fortschr Med; 2004 Oct; 146(44):57. PubMed ID: 15566254 [No Abstract] [Full Text] [Related]
34. [Lipid control in the double pack. Combined drugs to achieve the goal]. MMW Fortschr Med; 2002 Jun; 144(23):53. PubMed ID: 12119910 [No Abstract] [Full Text] [Related]
35. Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials. Kesäniemi A Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():29-30. PubMed ID: 18001318 [TBL] [Abstract][Full Text] [Related]
36. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia. Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099 [TBL] [Abstract][Full Text] [Related]
37. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients. Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864 [TBL] [Abstract][Full Text] [Related]
38. LDL-Cholesterol is the King. Goumas GS Angiology; 2009; 60(3):387-8. PubMed ID: 19497926 [No Abstract] [Full Text] [Related]
39. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction. Robinson JG; Davidson MH Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):461-76. PubMed ID: 16918265 [TBL] [Abstract][Full Text] [Related]